Seminars in Hematology
Volume 46, Supplement 2 , Pages S26-S32, January 2009

Management of Chemotherapy-Induced Thrombocytopenia: Current Status of Thrombopoietic Agents

  • Saroj Vadhan-Raj

      Affiliations

    • Corresponding Author InformationAddress correspondence to Saroj Vadhan-Raj, MD, Chief, Section of Cytokines and Supportive Oncology, Professor of Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030

Section of Cytokines and Supportive Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Saroj Vadhan-Raj, MD, discloses the following: Investigator: Amgen, GSK.

PII: S0037-1963(08)00206-0

doi:10.1053/j.seminhematol.2008.12.007

Seminars in Hematology
Volume 46, Supplement 2 , Pages S26-S32, January 2009

Article Tools

* Image Usage & Resolution